Literature DB >> 17878403

Constitutively active STAT6 predisposes toward a lymphoproliferative disorder.

Mark H Kaplan1, Sarita Sehra, Hua-Chen Chang, John T O'Malley, Anubhav N Mathur, Heather A Bruns.   

Abstract

Signal transducer and activator of transcription 6 (STAT6) is critical for IL-4 and IL-13 responses, and necessary for the normal development of Th2 cells. We previously generated mice that express a constitutively active STAT6 (STAT6VT) under control of the CD2 locus control region, which directs expression to the T-cell compartment. We now describe that a small proportion of these mice (~5%) develop a spontaneous lymphoproliferative disease (LPD) that results in dramatic splenomegaly. The cell populations observed in the LPD spleens can be divided into 2 categories, those that are composed of mixed lineage cells and those that are predominantly T cells with a phenotype similar to that in autoimmune lymphoproliferative syndrome (ALPS) patients. These data suggest that while active STAT6 is not a transforming factor, expression in T cells predisposes toward the development of lymphoproliferative disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878403      PMCID: PMC2234780          DOI: 10.1182/blood-2007-06-098244

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response.

Authors:  M H Kaplan; J R Whitfield; D L Boros; M J Grusby
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

2.  A gain-of-function mutation in STAT6.

Authors:  C Daniel; A Salvekar; U Schindler
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

Review 3.  The role of constitutively active Stat6 in leukemia and lymphoma.

Authors:  Heather A Bruns; Mark H Kaplan
Journal:  Crit Rev Oncol Hematol       Date:  2005-10-05       Impact factor: 6.312

4.  IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis.

Authors:  J F Urban; N Noben-Trauth; D D Donaldson; K B Madden; S C Morris; M Collins; F D Finkelman
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

5.  Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome.

Authors:  Yae-Jean Kim; Janet K Dale; Pierre Noel; Margaret R Brown; Thomas B Nutman; Stephen E Straus; Amy D Klion
Journal:  Am J Hematol       Date:  2007-07       Impact factor: 10.047

6.  Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.

Authors:  I J Fuss; W Strober; J K Dale; S Fritz; G R Pearlstein; J M Puck; M J Lenardo; S E Straus
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

Review 7.  Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.

Authors:  Eric B Haura; James Turkson; Richard Jove
Journal:  Nat Clin Pract Oncol       Date:  2005-06

Review 8.  Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.

Authors:  Austen Worth; Adrian J Thrasher; H Bobby Gaspar
Journal:  Br J Haematol       Date:  2006-04       Impact factor: 6.998

9.  Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells.

Authors:  Heather A Bruns; Ulrike Schindler; Mark H Kaplan
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

10.  NRAS mutation causes a human autoimmune lymphoproliferative syndrome.

Authors:  João B Oliveira; Nicolas Bidère; Julie E Niemela; Lixin Zheng; Keiko Sakai; Cynthia P Nix; Robert L Danner; Jennifer Barb; Peter J Munson; Jennifer M Puck; Janet Dale; Stephen E Straus; Thomas A Fleisher; Michael J Lenardo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-16       Impact factor: 11.205

View more
  7 in total

1.  The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.

Authors:  Michael D Howell; Peisong Gao; Byung Eui Kim; Leighann J Lesley; Joanne E Streib; Patricia A Taylor; Daniel J Zaccaro; Mark Boguniewicz; Lisa A Beck; Jon M Hanifin; Lynda C Schneider; Tissa R Hata; Richard L Gallo; Mark H Kaplan; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2011-07-18       Impact factor: 10.793

2.  PTB-associated splicing factor (PSF) functions as a repressor of STAT6-mediated Ig epsilon gene transcription by recruitment of HDAC1.

Authors:  Lijie Dong; Xinyu Zhang; Xiao Fu; Xianzhi Zhang; Xingjie Gao; Mengyu Zhu; Xinting Wang; ZhenXia Yang; Ole Nørregaard Jensen; Juha Saarikettu; Zhi Yao; Olli Silvennoinen; Jie Yang
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

3.  Live cell imaging reveals continuous STAT6 nuclear trafficking.

Authors:  Hui-Chen Chen; Nancy C Reich
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

4.  Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR.

Authors:  Anna Hutchinson; Guillermo Reales; Thomas Willis; Chris Wallace
Journal:  PLoS Genet       Date:  2021-10-20       Impact factor: 6.020

5.  Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.

Authors:  Olga Ritz; Chrystelle Guiter; Flavia Castellano; Karola Dorsch; Julia Melzner; Jean-Philippe Jais; Gwendoline Dubois; Philippe Gaulard; Peter Möller; Karen Leroy
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

6.  Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.

Authors:  Douglas G Walker; Jessica E Dalsing-Hernandez; Nicole A Campbell; Lih-Fen Lue
Journal:  Exp Neurol       Date:  2008-09-24       Impact factor: 5.330

7.  Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly.

Authors:  Minjun Yu; Jose L Moreno; Joseph P Stains; Achsah D Keegan
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.